Le Lézard
Classified in: Health
Subject: SVY

Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/4263060


GlobalData's Medical Devices sector report, "Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Melanoma Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Melanoma Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Melanoma Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Melanoma Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Melanoma Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/4263060

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com  

SOURCE ReportBuyer


These press releases may also interest you

at 09:30
DUBLIN, October 23, 2017 /PRNewswire/ -- The "China Contract Research Organization(CRO) Industry Report, 2017-2021" report has been added to Research and Markets' offering. Under the pressure from higher R&D costs, longer R&D cycle and lower R&D...

at 09:30
ALBANY, New York, October 23, 2017 /PRNewswire/ -- Rising instances of stretch marks in people of various age-groups is catalyzing growth in the global stretch marks treatment market. Growing prevalence of obesity on account of increasing...

at 09:29
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Oct. 23, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it has received Notice of...

at 09:07
ROCKLAND, Mass., Oct. 23, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced the appointment of Robert Truckenmiller as Senior Vice President, Market Access &...

at 09:05
COTTONWOOD HEIGHTS, Utah, Oct. 23, 2017 /PRNewswire/ -- Dynatronics Corporation (NASDAQ:DYNT) today announced that it has signed an exclusive distribution agreement ("Strategic Alliance") for the United States with Zimmer MedizinSysteme GmbH (Zimmer)...

at 09:01
LONDON, October 23, 2017 /PRNewswire/ -- Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs The Latin American Pharmaceutical Market is expected to grow at a CAGR of 9.3% in...




News published on 6 october 2017 at 10:33 and distributed by: